PMC Bank crisis: Fourth death 83-year-old unable to pay for surgery

Agencies
October 19, 2019

Mumbai, Oct 19: An 83-year-old depositor of the troubled PMC Bank died on Friday, with his family claiming that they could not raise money for his heart surgery after restrictions were imposed on fund withdrawals.

This is a fourth incident of the death of a depositor of the Punjab & Maharashtra Cooperative Bank after the RBI appointed administrator on the city-headquartered lender.

Two of the depositors had died of cardiac arrest, while another, a woman doctor, allegedly committed suicide.

Murlidhar Dharra (83) died at his home in suburban Mulund on Friday, his son Prem Dharra told news agency.

The family had a total of Rs 80 lakh in deposits with the bank (which was placed under restrictions since September 24), he said.

Doctors had recommended heart surgery for his father, but they could not arrange the money as the deposits are stuck at the bank, Prem said.

It can be noted that under the RBI directions, exceptions can be made for medical emergencies. It was not known immediately whether the PMC Bank refused a request from the family under this provision.

After an alleged Rs 4,355 crore scam came to light at the bank, the RBI initially capped withdrawals at Rs 1,000 in view of liquidity crisis, and later hiked it to Rs 40,000 in three moves.

The depositors have been protesting over the last three weeks, seeking their money back.

On Tuesday, 51-year-old Sanjay Gulati, who had recently lost his job with Jet Airways when the airline was grounded, died of a heart attack hours after attending a depositors' protest.

It was followed by alleged suicide of Dr Nivedita Bijlani, and death of Mulund-resident Fatto Punjabi due to cardiac arrest.

The crisis at the bank is being attributed to loans given to realty player HDIL, which were allegedly hidden from regulators' scrutiny, turning non-performing assets.

Five persons, including HDIL promoters, have been arrested in the case.

Comments

INDIAN
 - 
Saturday, 19 Oct 2019

now you want hindutva country...then vote for modi and die.

 

am very sad that one innocent human died...this man made money for his last life but the money never helped him..

 

Politician say vote for BJP we will save hindu people, but in reallity they say lie and make you belive that muslim is your enemy.

 

In mangalore most hindus & muslims are good people they cooperate each other in all scenerio but please dont belive in political guy who use you only for his power and money to feed his family..

 

 

 

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 16,2020

Varanasi, Feb 16: Amidst continuing protests against the amended citizenship law, Prime Minister Narendra Modi on Sunday said his government stood by the decision despite all pressure.

"Be it the decision on Article 370 or the Citizenship Amendment Act, it was necessary in the interest of the country. Despite pressure, we stand by our decision and will remain so," he said.

Modi was addressing a public meeting in his Lok Sabha constituency.

Prime Minister Narendra Modi also asserted that the trust set up for construction of the Ram temple in Ayodhya will work "rapidly".

"A trust has been formed for construction of a grand Ram temple in Ayodhya. This trust will work rapidly," he said at a public meeting during his day-long visit to his Lok Sabha constituency.

The government had recently set up the Shri Ram Janmabhoomi Teerth Kshetra on the Supreme Court's directive to the Union government to form a trust that can look into the construction and management of the temple.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 5,2020

Ayodhya, Aug 5: After laying the foundation stone for the Ram temple in Ayodhya on Wednesday, Prime Minister Narendra Modi termed the 'bhoomi pujan' event as an "emotional moment" for the entire country and added that "every heart is illuminated today".

"Every heart is illuminated; it is an emotional moment for the entire country... A long wait ends today... A grand temple will now be built for our Ram Lalla who had been living under a tent for many years," said Prime Minister Modi at foundation stone-laying ceremony of the Ram temple.

"With the construction of this temple, not only history is being made, but is being repeated. 

The way boatmen to tribals helped Lord Ram, the way children helped Lord Krishna lift Govardhan mountain, similarly, with everyone's efforts temple construction will be completed," he added.

Earlier today, Prime Minister Modi conducted 'bhoomi pujan' for the construction work of Ram temple.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.